Spyre Therapeutics, Inc. (SYRE)
86.17
-0.92
(-1.06%)
USD |
NASDAQ |
Sep 25, 15:32
Spyre Therapeutics Cash from Operations (TTM) : -209.47M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -209.47M |
| March 31, 2026 | -185.87M |
| December 31, 2025 | -169.41M |
| September 30, 2025 | -162.30M |
| June 30, 2025 | -154.68M |
| March 31, 2025 | -170.36M |
| December 31, 2024 | -157.82M |
| September 30, 2024 | -151.32M |
| June 30, 2024 | -156.42M |
| March 31, 2024 | -110.82M |
| December 31, 2023 | -99.91M |
| September 30, 2023 | -87.01M |
| June 30, 2023 | -67.48M |
| March 31, 2023 | -71.52M |
| December 31, 2022 | -80.14M |
| September 30, 2022 | -81.27M |
| June 30, 2022 | -83.20M |
| March 31, 2022 | -60.45M |
| December 31, 2021 | -53.72M |
| September 30, 2021 | -51.58M |
| June 30, 2021 | -52.12M |
| March 31, 2021 | -73.61M |
| Date | Value |
|---|---|
| December 31, 2020 | -75.78M |
| September 30, 2020 | -74.94M |
| June 30, 2020 | -74.61M |
| March 31, 2020 | -71.58M |
| December 31, 2019 | -65.69M |
| September 30, 2019 | -56.60M |
| June 30, 2019 | -47.89M |
| March 31, 2019 | -40.55M |
| December 31, 2018 | -32.19M |
| September 30, 2018 | -30.87M |
| June 30, 2018 | -29.73M |
| March 31, 2018 | -26.63M |
| December 31, 2017 | -24.62M |
| September 30, 2017 | -23.10M |
| June 30, 2017 | -21.59M |
| March 31, 2017 | -20.28M |
| December 31, 2016 | -18.84M |
| September 30, 2016 | -15.32M |
| June 30, 2016 | -13.26M |
| March 31, 2016 | -12.49M |
| December 31, 2015 | -10.98M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| AbbVie, Inc. | 19.51B |
| Incyte Corp. | 1.980B |
| SELLAS Life Sciences Group, Inc. | -28.42M |
| BridgeBio Pharma, Inc. | -434.37M |
| Relay Therapeutics, Inc. | -212.20M |